Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Daridorexant
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Daridorexant 50mg tablets
0401040A0AAABAB
|
Daridorexant | Daridorexant | Central Nervous System | 5,726 |
|
Daridorexant 25mg tablets
0401040A0AAAAAA
|
Daridorexant | Daridorexant | Central Nervous System | 3,006 |
|
Quviviq 50mg tablets
0401040A0BBABAB
|
Quviviq | Daridorexant | Central Nervous System | 171 |
|
Quviviq 25mg tablets
0401040A0BBAAAA
|
Quviviq | Daridorexant | Central Nervous System | 121 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.